Ranimustine

雷莫司汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRanimustine
Drug Alias Nameranimustina雷诺氮芥ranimustineranimustinumCymerin +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA cross linking agents
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1987/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNipro Corp
China Registration ClassN/A

Develop Information

Active CompaniesNipro Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01AD07
Related LinksWikipediaKEGG